Early Development GMPs for Drug-Product Manufacturing of Small Molecules: An Industry Perspective (Part III)ByRichard Creekmore,Amnon Eylath,John W. Skoug,Jackson Pellett,Michael Lovdahl,Dennis Joiner,Eleni Dokou,Eric SchmittAugust 2nd 2012IQ Consortium representatives explore industry approaches and practices for applying GMPs in early development.